Fetal hyperinsulinism is probably the major cause of increased weight due to fat deposition in the neonate, although there are also other endocrine disturbances which may be important (Pedersen 1977) . There is now further evidence for this, recently presented by Whitelaw (1977) , who showed a relationship between the amount ofsubcutaneous fat in the neonate assessed by skin-fold measurements and the average blood glucose levels during the last trimester of the pregnancy.
Good diabetic control should reduce fetal hyperinsulinism. This might be related in turn to a reduction of respiratory distress syndrome, since it has been suggested that hyperinsulinism may delay surfactant maturation (Smith et al. 1975) . Indeed, in recent years improvements in diabetic control have been parallelled by the almost complete disappearance of respiratory distress syndrome as a cause of neonatal death (Essex 1976) . There is also a suggestion by Mr J M Brudenell (p 207) that fetal distress during labour may be prevented by avoiding hyperglycaemia. These observations provide a rational basis for maintaining normal blood glucose levels during pregnancy and labour.
The aim of the diabetic physician, therefore, must be to maintain a very high standard of diabetic control throughout pregnancy and to keep blood glucose levels as near physiological as possible, even in the very mild chemical or group A diabetics in whom fetal mortality is also increased (O'Sullivan 1975) . This control is achieved by diet alone or diet together with insulin. With regard to oral hypoglycaemics, have reported the safety of small doses ofchlorpropamide (l00 mg daily) in pregnancy, although there is a small danger of serious neonatal hypo glycaemia if oral hypoglycaemics are not stopped about forty-eight hours before delivery. Despite the absence of any confirmed teratogenic effect of these drugs (Malins et al. 1964) , they are not generally given during pregnancy and insulin is used in preference when diet alone has failed. Dietary measures alone prove adequate to control the majority of chemical or group A diabetics during pregnancy. The criteria for good control need to be strict and urine tests should be negative for glucose, while postprandial blood glucose levels should be kept below 7.0 mmol/l. If this fails, insulin is used. Sometimes only small amounts are needed, given by a single daily injection, although occasionally these patients need quite large twice-daily doses. It is probably best to use one of the new purified insulins in these cases, thereby avoiding insulin antibody production in most of them. This is a small theoretical advantage -especially if insulin is needed again in later years -although there is still nothing to suggest that insulin antibodies are harmful. There is no good reason to give all group A diabetics insulin, although O'Sullivan (1975) has suggested that improved fetal survival resulted when higher risk pregnancies were given insulin routinely. Of24 consecutive chemical diabetics treated at King's College Hospital in the years 1971-1975, only 6 required insulin during their pregnancy and none continued to need insulin after delivery. There was only one fetal death.
Established diabetics should be obsessionally controlled throughout pregnancy, if possible from the time ofconception. The cause of the disturbing increase in congenital malformations, reviewed here by Professor Malins (p 205), is unknown and at present we can only attempt to obtain optimal control in the first trimester as well as during the rest of the pregnancy. For this reason, we try to advise all prospective mothers to establish good control prior to planned pregnancies and to report the pregnancy itself as early as possible.
Diabetic control must be maintained by the patient by means of regular urine tests up to four times daily, with appropriate adjustments of the insulin dose, and at ante-natal clinics, postprandial blood glucose levels usually should be less than 7-8 mmol/l. Some centres have even presented their diabetics with Ames Reflectance Meters to use at home. Patients are admitted to hospital at 32 weeks and then it is possible to improve control still further, maintaining blood glucose levels below 5.5 mmol/l for most of twenty-four hours. Gillmer et al. (1975) studied diurnal blood glucose rhythms at this stage of pregnancy showing that these physiological levels can be achieved in practice, although mid-morning levels tended to be higher. More recently, results have improved still further and Essex (1976) reported that the average blood glucose in our patients during this period has been reduced to 4.9 mmol/l (87 mg/100 ml). Quite low blood glucose levels are sometimes recorded, especially at night (Gillmer et al. 1975) , but hypoglycaemic symptoms are relatively infrequent and almost always mild. There is no evidence that these mild hypoglycaemic episodes are harmful to the fetus.
Insulin should be given twice daily to all but the very mildest cases. Soluble or Actrapid (monocomponent) insulins can be used on their own, but most patients are best controlled by a mixture of one of these insulins together with a medium-acting insulin. Soluble and isophane insulins mixed together and used twice daily represent a well tried and successful regime; Actrapid (purified neutral soluble, monocomponent) and Leo Retard (purified isophane) insulins can be used in the same way, although there is no reason to transfer established, already well-controlled patients to these new insulins. Other medium or long acting purified insulins such as Semitard and Monotard can also be used. There is rarely a need for a third injection. The insulin requirement increases through pregnancy especially after the 28th week. The dose increase varies considerably and is frequently 50-100% higher than before pregnancy. It may be much more than this or not occur at all. It is probably due, in part. to the increasing level of placental lactogen (Ursell et al. 1973) , although the correlation is not a very close one.
Corticosteroids have a potent hyperglycaemic effect and when these are given to accelerate maturation of the lungs in patients threatening premature labour, severely uncontrolled diabetes can result within a few hours ofstarting treatment, leading to a substantial increase in insulin requirement. In order to avoid severe hyperglycaemia, the additional insulin can be given by intramuscular injection starting with 4 u/h of soluble or Actrapid insulin, or by continuous intravenous infusion starting with 2 u h and increasing this as required according to blood glucose measurements. The technique is described below. There are also problems when intravenous salbutamol or ritodrine are used, and besides their known hyperglycaemic effect (Neville et al. 1977 , Steel & Parboosingh 1977 , a dangerous metabolic acidosis may ensue as a result of an increase of lactate and ketones (Baillie 1976 , Chapman 1977 . More insulin is needed and very careful observation is required (Leslie & Coats 1977) . Optimal blood glucose control is also desirable during labour and reasons why hyperglycaemia might increase fetal distress are discussed by Mr Brudenell. Our practice, and that of others (West & Lowy 1977) , is to give the insulin by constant intravenous infusion. The usual subcutaneous dose is maintained until the night previously and then on the morning of induction 500 ml of 5% glucose is given intravenously every four hours concurrently with the insulin infusion. Soluble or Actrapid insulin is prepared at a concentration of0.5 or 1.0 u/ml of normal saline in a syringe, and administered by infusion pump at a rate of 2 u/h regardless of the previous insulin dose. The tubing from the infusion syringe is connected to the drip tubing by a Y connector, a technique which has been used very successfully for the treatment of ketoacidosis (Page et al. 1974) . Blood glucose levels are easy to control in this way and the majority can be kept below 7 mmol/l throughout labour ofalmost any duration ( Figure I) . The range of insulin infusion rates varies between 0.5 and 3.0 uh and is adjusted according to blood glucose measurements made every 1-2 hours. Much of the blood glucose fluctuation is due to varying glucose drip rates, although this is less of a problem using 5 0 0 in preference to the 8% glucose solution used in earlier cases. Using this technique, there is much less anxiety than previously to terminate a long labour by Caesarean section because of the risk of deteriorating diabetic control.
After labour it is vital to return to the pre-pregnancy dose ofsubcutaneous insulin. There is a danger of profound and very serious hypoglycaemia if the high doses needed during late pregnancy are given, since the requirement drops almost immediately after delivery.
Attention to diabetic control through pregnancy and labour has become progressively more obsessional during recent years and has been accompanied by a considerable improvement in fetal survival. It is likely that improved control is at least one of the factors actually responsible for this improvement. Before 1950 the fetal loss rate in diabetic pregnancy, according to figures collected from major centres in Britain, Europe and the USA, was 40% (Henley 1947). In 1958, Hagbard noted a striking improvement in fetal mortality from 44.5% to 26.2°0 during the period 1951-1954and attributed this change to the setting up of a special clinic for diabetic pregnancy and to the policy of early delivery at 35 to 37 weeks. Other centres using these methods achieved similar results. Further efforts to maintain good control of the diabetes and also, perhaps, the greater involvement of paediatricians, reduced the loss rate to 10-15% during the years 1960-1970. Since 1970there has been a greater emphasis on the goal of perfect diabetic control with blood glucose levels not exceeding 5.6 mrnol/l at any time and a tendency to aim for delivery at 38 weeks or later (Essex et al. 1973) . Probably as a result of these policies fetal mortality rates of5-10% are recorded, but we have to remember that the management of pregnancy and, even more, of the newborn child has improved greatly in the last twenty years and especially in those aspects which are most relevant to the diabetic mother.
As other causes of fetal death have been reduced, the contribution of congenital malformations has become relatively greater at the Birmingham Maternity Hospital and there is also an absolute increase in their number, both fatal and non-fatal (Table I) . The importance of malformations in relation to the fetal loss rate appears in Table 2 , which shows that in the years 1970-1974 half of the fetal deaths~ere due to lethal malformations (Soler et al. 1976) . We have, throughout, adopted the definition of Pedersen et al. (1974) , including only defects 0141-0768/78/0071-0205/$01.000
